NVCT
Nuvectis Pharma Inc
NASDAQ: NVCT · HEALTHCARE · BIOTECHNOLOGY
$10.00
+2.99% today
Updated 2026-05-06
Market cap
$268.66M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.31
Dividend yield
—
52W range
$6 – $11
Volume
0.1M
Nuvectis Pharma Inc (NVCT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-188.00%
ROA
-68.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | — | $-10000.00 | — | — | — |
| 2021 | $0.00 | $-12.89M | — | — | — |
| 2022 | $149000.00 | $-18.79M | -12,808.72% | -12,908.72% | -12,608.72% |
| 2023 | $0.00 | $-22.26M | — | — | — |
| 2024 | $0.00 | $-19.00M | — | — | — |
| 2025 | $0.00 | $-26.44M | — | — | — |